Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
These contrasted with the conclusions drawn from the multicentre trial by Watson et<br />
al 109 who found that crude intervention group actuarial survival rates were marginally<br />
better yet of borderline statistical significance (unstated statistic, p = 0.08). Various<br />
stratification techniques uncovered highly statistically significant survival benefits for the<br />
intervention protocol in patients with stage III disease after controlling for centre effects<br />
(p = 0.009). The relevance of these post-hoc analyses is unknown but they are<br />
unsatisfactory when performed without substantial protection from increasing the<br />
probability of detecting a significant difference when none exists (Type I error).<br />
Fletcher et al 110 and Glassburn et al, 111 failed to detect statistically significant survival<br />
advantages between intervention and comparison groups (Table 70). The study by<br />
Johnson and Walton 112 selectively report the experience of a subset of participants<br />
without divulging the overall comparisons described in their methods section. The<br />
experience of 14 subjects assigned to the comparison group are undisclosed. If<br />
conservative assumptions are applied (ie, that all missing comparison group subjects<br />
died), then the intervention protocol is found to be statistically significantly associated<br />
with death over five years (p = 0.0449).<br />
Table 70 Outcomes following treatment for cervical cancer in intervention and comparison<br />
groups. 110,111<br />
Outcome<br />
Fletcher 1977<br />
Intervention Group Comparison Group p<br />
110<br />
Sample size (n)<br />
Five-year disease free survival (%)<br />
Glassburn 1974 111<br />
Sample size (n)<br />
27-month disease-free survival (%)<br />
Johnson 1974 112<br />
Sample size (n)<br />
Five-year disease-free survival (%)<br />
<strong>Hyperbaric</strong> oxygen therapy 71<br />
109<br />
33.0<br />
17<br />
41.1<br />
25<br />
44.0<br />
124<br />
41.1 0.2021<br />
23<br />
39.1 0.8961<br />
25<br />
16.0 0.0308<br />
Summary<br />
The studies failed to provide enough evidence to come to firm conclusions about the<br />
effectiveness of exposure to HBO in conjunction with radiotherapy for cervical cancer.<br />
Any conclusions reached from these studies would need to take into consideration the<br />
disparity in intervention and comparison protocols, poor methodological descriptions,<br />
and substantial post-hoc comparisons.<br />
Bladder cancer<br />
Four studies were retrieved from the published literature, and judged to meet inclusion<br />
and exclusion criteria (Table 71).